iSpecimen Inc reports results for the quarter ended in December - Earnings Summary

iSpecimen

13/03/2024 23:11

* iSpecimen Inc  ISPC.OQ  reported a quarterly adjusted loss
of 32
cents​​ per share for the quarter ended in December, lower than
the same quarter last year, when the company reported EPS of -24
cents.  The lone analyst forecast for the quarter was for a loss
of 24 cents per share. 
    * Revenue fell 13% to $2.58 million from a year ago;
analysts
expected $3.04 million. 
    * iSpecimen Inc's reported EPS for the quarter was a loss
of 34
cents​.
    * The company reported a quarterly loss of $3.07 million.
    * iSpecimen Inc shares had fallen by 18.1% this quarter.

FORECAST CHANGES
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the software peer
group
is also "buy"

Wall Street's median 12-month price target for iSpecimen Inc is
$5.00 
This summary was machine generated from LSEG data March 13 at
11:11 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2023      -0.24          -0.32          Missed
 Sep. 30 2023      -0.35          -0.23          Beat
 Jun. 30 2023      -0.30          -0.39          Missed
 Mar. 31 2023      -0.32          -0.27          Beat